AUUCX
Price
$17.65
Change
+$0.30 (+1.73%)
Updated
Apr 11 closing price
Net Assets
262.58M
FXAIX
Price
$186.26
Change
+$3.31 (+1.81%)
Updated
Apr 11 closing price
Net Assets
597.55B
Ad is loading...

AUUCX vs FXAIX

Header iconAUUCX vs FXAIX Comparison
Open Charts AUUCX vs FXAIXBanner chart's image
AB Select US Equity C
Price$17.65
Change+$0.30 (+1.73%)
VolumeN/A
Net Assets262.58M
Fidelity 500 Index
Price$186.26
Change+$3.31 (+1.81%)
VolumeN/A
Net Assets597.55B
AUUCX vs FXAIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
AUUCX vs. FXAIX commentary
Apr 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AUUCX is a Buy and FXAIX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
FXAIX has more cash in the bank: 598B vs. AUUCX (263M). FXAIX pays higher dividends than AUUCX: FXAIX (1.30) vs AUUCX (0.00). AUUCX was incepted earlier than FXAIX: AUUCX (13 years) vs FXAIX (14 years). AUUCX (2.24) is less costly to investors than FXAIX (0.01). AUUCX is a more actively managed with annual turnover of: 171.00 vs. FXAIX (2.00). FXAIX has a lower initial minimum investment than AUUCX: FXAIX (0) vs AUUCX (2500). FXAIX annual gain was more profitable for investors over the last year : 2.68 vs. AUUCX (-5.66). FXAIX return over 5 years is better than : 103.82 vs. AUUCX (26.55).
AUUCXFXAIXAUUCX / FXAIX
Total Expense Ratio2.240.0114,933%
Annual Report Gross Expense Ratio2.240.0114,933%
Fund Existence13 years14 years-
Gain YTD-8.104-10.11780%
Front LoadN/AN/A-
Min. Initial Investment25000-
Min. Initial Investment IRAN/AN/A-
Net Assets263M598B0%
Annual Yield % from dividends0.001.30-
Returns for 1 year-5.662.68-211%
Returns for 3 years3.1525.4212%
Returns for 5 years26.55103.8226%
Returns for 10 years13.03175.067%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OANGX31.690.62
+2.00%
Oakmark Global Institutional
EUGDX25.69N/A
N/A
Morgan Stanley Europe Opportunity I
BRWCX20.13N/A
N/A
MFS Blended Research Growth Eq C
LAMSX20.83N/A
N/A
Lord Abbett Dividend Growth R4
AYRWF0.14N/A
-2.27%
AYR WELLNESS INC.